Form 8-K INVIVO THERAPEUTICS HOLD For: Feb 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Lumentum shares fall after hitting 52-week high
- Stryker invests $400M in CMR Surgical with option to acquire
Invivo Therapeutics (NVIV) files for Chapter 11 bankruptcy
February 1, 2024 8:07 AM ESTInvivo Therapeutics (NASDAQ: NVIV) disclosed:
On February 1, 2024, after considering all strategic alternatives, InVivo Therapeutics Holdings Corp. and its subsidiary InVivo Therapeutics Corporation (together, the Company) filed voluntary petitions (the Voluntary Petitions) for relief under the provisions of Chapter 11 of Title 11 of the United States... More



